Colgate-Palmolive Company (NYSE:CL) saw a downside of -0.74% to close Tuesday at $76.33 after subtracting -$0.57 on the day. The 5-day average trading volume is 4,010,380 shares of the company’s common stock. It has gained $77.85 in the past week and touched a new high 1 time within the past 5 days. An average of 5,272,905 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 5,187,098.
CL’s 1-month performance is 0.58% or $0.74 on its low of $73.75 reached on 07/28/23. The company’s shares have touched a 52-week low of $67.84 and high of $83.81, with the stock’s rally to the 52-week high happening on 05/15/23. YTD, CL has lost -3.12% or -$2.46 and has reached a new high 7 times. However, the current price is down -8.92% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CL stock investors last saw insider trading activity on Aug 02.Kooyman John W (Chief of Staff) most recently sold 21,677 shares at $77.69 per share on Aug 02. This transaction cost the insider $1,684,062. CLO and Secretary, Daniels Jennifer, sold 24,703 shares at a price of $79.70 on May 19. Then, on May 15, Chief Human Resources Officer Massey Sally sold 14,594 shares at a price of $81.55 per share. This transaction amounted to $1,190,141.
Valuation Metrics
CL stock has a beta of 0.48. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 3.39 while the price to cash flow ratio at 100.26.
Colgate-Palmolive Company’s quick ratio for the period ended June 29 was 0.70, with the current ratio over the same period at 1.20.. In terms of profitability, the gross margin trailing 12 months is 56.90%. The trailing 12-month EBITDA margin is 22.99% while for the period ending June 29, Colgate-Palmolive Company’s operating margin was 14.80%. The firm’s gross profit as reported stood at $10.25 billion against revenue of $17.97 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -11.35% to $502.0 million, while revenue of $5.0 million was 99.0% off the previous quarter. Analysts expected CL to announce $0.68 per share in earnings in its latest quarter, but it posted $0.7, representing a 2.90% surprise. EBITDA for the quarter stood at more than $1.12 billion. CL stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 15.91 billion, with total debt at $8.99 billion. Shareholders hold equity totaling $826.69 million.
Let’s look briefly at Colgate-Palmolive Company (CL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 46.62% to suggest the stock is trending Neutral, with historical volatility in this time period at 16.46%.
The stock’s 5-day moving average is $76.72, reflecting a -0.40% or -$0.31 change from its current price. CL is currently trading +1.25% above its 20-day SMA, +4.66% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +0.10% and SMA200 by+6.38%.
Stochastic %K and %D was 59.20% and 61.93% and the average true range (ATR) pointed at 1.18. The RSI (14) points at 47.86%, while the 14-day stochastic is at 55.60% with the period’s ATR at 1.17. The stock’s 9-day MACD Oscillator is pointing at -0.09 and -0.41 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Colgate-Palmolive Company (NYSE: CL), Citigroup launched coverage with a Buy rating. Analysts offering their rating for CL stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate CL as a “sell,”, while 13 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 9 have offered a “buy” rating.
What is CL’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $68.00 and a high of $98.00, with their median price target at $85.00. Looking at these predictions, the average price target given by analysts is for Colgate-Palmolive Company (CL) stock is $85.33.